Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.30
    OpenPayerPolicy UpdatesOtorhinolaryngology (ENT)Premera WA Chronic Rhinitis Coverage Update | Open…
    Ask Trek AI about this page
    ModifiedPremera Blue Cross of WashingtonPolicy 7.01.610

    Cryoablation, Radiofrequency Ablation, and Laser Ablation for Treatment of Chronic Rhinitis

    Customize your policy alerts

    Sign up for premerabluecrossofwashington Policy 7.01.610 alerts

    Get alerted when Policy 7.01.610 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage of cryoablation, radiofrequency ablation, laser ablation, and posterior nasal nerve resection for allergic or nonallergic chronic rhinitis. These procedures are considered investigational.

    Policy Summary
    PayerPremera Blue Cross of Washington
    PolicyCryoablation, Radiofrequency Ablation, and Laser Ablation for Treatment of Chronic Rhinitis
    Policy CodePolicy 7.01.610
    Change TypeModified
    Effective DateFebruary 5, 2027
    Next Review DateN/A
    Key ActionTreat cryoablation, radiofrequency ablation, laser ablation, and posterior nasal nerve resection for chronic rhinitis as investigational and at risk of denial.
    SourceLink
    POLICY UPDATE CHANGES

    The policy added a statement that resection (neurectomy) of the posterior nasal nerve for chronic rhinitis is considered investigational.

    Policy 7.01.610 replaced policy 7.01.168.

    The policy was updated in August 2026 with literature through March 9, 2026, while policy statements remained unchanged.

    The policy removed unlisted codes 30999 and 31299 in May 2025 after CPT codes for RhinAer and ClariFix were established.

    The policy added CPT codes 31242 and 31243 and a termination date to HCPCS code C9771 in January 2024.

    4Investigational procedures
    3CPT codes listed
    10%–22%Persistent symptoms despite medical therapy
    3FDA-cleared device systems

    Investigational Chronic Rhinitis Procedures

    Investigational Procedures

    The following procedures are considered investigational for allergic or nonallergic chronic rhinitis:

    Investigational procedures

    • Cryoablation for chronic rhinitis is considered investigational, including use of the Clarifix device.
    • Radiofrequency ablation for chronic rhinitis is considered investigational, including use of the RhinAer stylus.
    • Laser ablation for chronic rhinitis is considered investigational.
    • Posterior nasal nerve resection: Resection or neurectomy of the posterior nasal nerve for chronic rhinitis is considered investigational.

    Posterior Nasal Nerve Resection

    The policy considers the following service investigational:

    Posterior nasal nerve resection: Resection (neurectomy) of the posterior nasal nerve for chronic rhinitis is considered investigational.

    Codes and Clinical Outcome Measures

    CPT CodesCPTNot Covered
    30117Excision or destruction (e.g., laser), intranasal lesion; internal approach.
    31242Nasal/sinus endoscopy, surgical; with destruction by radiofrequency ablation, posterior nasal nerve (use to report: RhinAer).
    31243Nasal/sinus endoscopy, surgical; with destruction by cryoablation, posterior nasal nerve (use to report: Clarifix).
    Reflective Total Nasal Symptom Score MCID
    MeasureReflective Total Nasal Symptom Score (rTNSS)
    Minimum clinically important differenceChange of 1 point
    Proposed baseline thresholdAt least 30% change from baseline
    NOSE MCID
    MeasureNasal Obstruction Symptom Evaluation (NOSE)
    Minimum clinically important differenceNot established
    Score range0 to 100, with higher scores indicating worse nasal obstruction symptoms
    SNOT-20 MCID
    MeasureSino-Nasal Outcome Test-20 (SNOT-20)
    Minimum clinically important differenceChange in score of 0.8 or greater
    Score range0 to 5, with higher scores indicating a greater rhinosinusitis-related health burden
    SNOT-22 MCID
    MeasureSino-Nasal Outcome Test-22 (SNOT-22)
    Minimum clinically important differenceChange in score of 8.9 points
    Instrument descriptionSNOT-22 is a variation of SNOT-20 that includes questions on nasal obstruction and loss of smell and taste
    RQLQ MCID
    MeasureRhinoconjunctivitis Quality of Life Questionnaire (RQLQ)
    Minimum clinically important differenceChange in score of 0.5
    Scoring scaleSeven-point scale from 0 (no impairment) to 6 (maximal impairment)
    Mini-RQLQ MCID
    MeasureMini-Rhinoconjunctivitis Quality of Life Questionnaire (mini-RQLQ)
    Minimum clinically important differenceChange in score of 0.4
    Instrument formatIncludes 14 items across 5 domains

    Provider Coverage Actions

    Denial Risk

    Investigational chronic rhinitis procedures

    Coverage is at risk of denial because cryoablation, radiofrequency ablation, laser ablation, and posterior nasal nerve resection or neurectomy for allergic or nonallergic chronic rhinitis are considered investigational.

    • Cryoablation, including use of the Clarifix device, is investigational.
    • Radiofrequency ablation, including use of the RhinAer stylus, is investigational.
    • Laser ablation for chronic rhinitis is investigational.
    • The listed CPT codes are 30117, 31242, and 31243.
    Denial Risk

    Posterior nasal nerve resection is investigational

    Do not expect coverage for resection (neurectomy) of the posterior nasal nerve for chronic rhinitis; the policy considers this service investigational.

    • This applies to posterior nasal nerve resection or neurectomy for chronic rhinitis.
    • The policy statement was added with the policy replacement and provider notification history.

    Chronic Rhinitis Background

    Chronic rhinitis includes allergic, nonallergic, and mixed rhinitis. It involves ongoing inflammation of the nasal passages and may cause rhinorrhea, nasal congestion or obstruction, itching, sneezing, mucus in the throat, and reduced quality of life. Allergies are a common cause, but chronic rhinitis may also occur without an allergic trigger or may involve both allergic and nonallergic features.

    Initial management commonly includes medical therapy such as nasal steroids, anticholinergics, decongestants, and antihistamines; allergy shots may also be used when appropriate. Approximately 10%–22% of patients may continue to have symptoms despite medical therapy. Chronic rhinitis that does not improve after adequate medical treatment is referred to as refractory chronic rhinitis.

    Key Procedure and Clinical Definitions

    Posterior Nasal Nerve
    Nerve fibersFibers from the maxillary nerve and the postganglionic pterygoid nerve that emerge from the sphenopalatine ganglion
    Intended effect of interruptionSever the parasympathetic supply to the nose
    Expected physiologic effectReduce efferent parasympathetic stimulation of the nasal mucosa, including submucosal gland secretions and blood flow
    Refractory Chronic Rhinitis
    DefinitionChronic rhinitis that does not improve after adequate medical therapy
    Conditions includedChronic rhinitis may be allergic, nonallergic, or mixed
    Medical therapy examplesSteroids, anticholinergics, nasal decongestants, and antihistamines
    Cryoablation
    ProcedureAblation using extreme cold
    MechanismFreezes nerve endings near the back of the nose
    Intended resultStops nerve signals that contribute to chronic rhinitis symptoms
    Radiofrequency Ablation
    ProcedureAblation using an electric current
    MechanismHeats a small area of nerve tissue
    Intended resultStops nerve signals that contribute to chronic rhinitis symptoms
    Laser Ablation
    ProcedureAblation using intense light
    MechanismHeats and destroys nerve tissue
    Intended resultStops nerve signals that contribute to chronic rhinitis symptoms
    Policy Summary
    PayerPremera Blue Cross of Washington
    PolicyCryoablation, Radiofrequency Ablation, and Laser Ablation for Treatment of Chronic Rhinitis
    Policy CodePolicy 7.01.610
    Change TypeModified
    Effective DateFebruary 5, 2027
    Next Review DateN/A
    Key ActionTreat cryoablation, radiofrequency ablation, laser ablation, and posterior nasal nerve resection for chronic rhinitis as investigational and at risk of denial.
    SourceLink
    On This Page
    Investigational Chronic Rhinitis ProceduresCodes and Clinical Outcome MeasuresProvider Coverage ActionsChronic Rhinitis BackgroundKey Procedure and Clinical Definitions

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.